-+ 0.00%
-+ 0.00%
-+ 0.00%

SCIENTURE ANNOUNCES THIRD PATENT GRANT FOR ARBLI™ (LOSARTAN POTASSIUM) ORAL SUSPENSION, STRENGTHENING LONG-TERM MARKET EXCLUSIVITY THROUGH 2041

Reuters·05/06/2026 12:05:00

Please log in to view news